17-61686115-T-C

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateB3_Supporting

The NM_032043.3(BRIP1):c.2626A>G (p.Ser876Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene BRIP1 is a tumor suppressor gene (CancerMine: 11 TSG, 4 oncogene, 1 driver citations). The gene BRIP1 is a known oncogene (CancerMine: 11 TSG, 4 oncogene, 1 driver citations). The gene BRIP1 is a cancer driver gene (CancerMine: 11 TSG, 4 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S876N: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 483140); p.S876R: Uncertain_significance (ClinVar VariationId 421096, 2 stars); p.S876R: Uncertain_significance (ClinVar VariationId 2952700, 1 star); p.S876= (synonymous): Benign/Likely_benign (ClinVar VariationId 1332631, 2 stars)

Frequency

Genomes: not found (cov: 32)

Consequence

BRIP1
NM_032043.3 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 2.60

Publications

1 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting DNA helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032043.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_032043.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

BRIP1 NM_032043.3
MANE Select
HGVSc / HGVSpc.2626A>Gp.Ser876Gly
Exon rankExon 19 of 20
missense
Prot: NP_114432.2UniProt: Q9BX63-1

Ensembl Transcripts

BRIP1 ENST00000259008.7
TSL:1MANE Select
HGVSc / HGVSpc.2626A>Gp.Ser876Gly
Exon rankExon 19 of 20
missense
Prot: ENSP00000259008.2UniProt: Q9BX63-1
BRIP1 ENST00000682453.1
HGVSc / HGVSpc.2626A>Gp.Ser876Gly
Exon rankExon 20 of 21
missense
Prot: ENSP00000506943.1UniProt: Q9BX63-1
BRIP1 ENST00000683039.1
HGVSc / HGVSpc.2626A>Gp.Ser876Gly
Exon rankExon 20 of 21
missense
Prot: ENSP00000508303.1UniProt: Q9BX63-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:34
GnomAD4 genome
Cov:32
Showing 3 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.0000206 148458 0.00 074562
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Familial cancer of breast;C1836860:Fanconi anemia complementation group J (1)
-
1
-
Hereditary cancer-predisposing syndrome (1)

Computational Scores

AlphaGenome AVI
Uncertain19
AlphaMissense
Benign0.064
BayesDel_addAF
Benign0.0063T
BayesDel_noAF
Benign-0.23
CADD
Benign21
DANN
Uncertain0.99
DEOGEN2
Benign0.14T
Eigen
Benign0.18
Eigen_PC
Uncertain0.31
FATHMM_MKL
Uncertain0.86D
FuncVEP CTI
Benign0.080
GPN-Star LLR
N/A-4.4
GPN-Star score
N/A4.4
LIST_S2
Benign0.73T
M_CAP
Benign0.047D
MetaRNN
Benign0.23T
MetaSVM
Benign-0.29T
MutationAssessor
Uncertain2.1M
PhyloP100
Benign2.6
popEVE
Benign-3.5
PrimateAI
Benign0.43T
PROVEAN
Benign-1.6N
REVEL
Benign0.23
Sift
Benign0.30T
Sift4G
Benign0.42T
Varity_R
N/A0.21
VESM-3B
Benign-5.4
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.050
SpliceAI score (max)
Benign0.060
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.